Skip to content

GeneDx Holdings WGS Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$63.32M-258%-$17.67M-131%-$7.64M-171%$10.81M+266%-$6.53M
$6.81M-1.0%$6.88M+6.3%$6.47M+4.6%$6.19M+9.0%$5.68M+2.2%
$9M-8.0%$9.78M-7.6%$10.59M+35.5%$7.81M+96.2%$3.98M+40.0%
-$32.41M$0-100%$15.77M+51.3%$10.42M+2.3%$10.18M+420%
$6.45M+48.4%$4.35M-29.6%$6.17M+161%$2.37M-61.3%$6.13M+101%
-$17.26M-55.8%-$11.07M-136%-$4.69M+87.1%-$36.35M-286%-$9.41M-1,713%
$38.59M+66.4%$23.19M+115%$10.77M+3,012%$346K-97.5%$13.72M-55.8%
-$11.07M-223%$9.03M-58.7%$21.85M+185%-$25.58M-277%$14.49M
-$38.86M$9.6M+19.2%$8.05M+98.6%$4.05M+165%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does GeneDx Holdings's cash flow data come from?
Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.